Maria M.
- Country
- Bulgaria
- Department
- Clinic of Cardiology
Research Overview
- A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization
- Inclisiran for Prevention of Major Adverse Cardiovascular Events in High-Risk Primary Prevention Patients with Atherosclerotic Cardiovascular Disease
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
Data & Insights
Has run more than one trial at 852 of 1500 partner sites.
Specializations
Cardiovascular Disease Management
This investigator specializes in treating complex heart failure conditions, particularly focusing on innovative combination therapies and management strategies for patients with reduced ejection fraction. Their research extends to cases involving concurrent kidney function impairment.
- Heart Failure Treatment Optimization
- Cardiovascular Death Prevention
- Management of Post-Acute Coronary Syndrome
Preventive Cardiology
The investigator conducts research in atherosclerotic cardiovascular disease prevention and lipid management. Their work includes evaluation of novel therapeutic approaches for hypercholesterolemia and cardiovascular risk reduction in high-risk populations.
- Primary ASCVD Prevention
- Lipid-Lowering Therapy
- Cardiovascular Risk Management
Cardiac Rhythm Management
This specialist focuses on managing atrial fibrillation and its complications, with particular emphasis on stroke prevention strategies. Their expertise includes evaluating anticoagulation approaches for patients with complex cardiac conditions.
- Stroke Prevention in Atrial Fibrillation
- Systemic Embolism Prevention
- Anticoagulation Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.